3-methoxytyramine has been researched along with Head and Neck Neoplasms in 5 studies
3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.
Head and Neck Neoplasms: Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)
| Excerpt | Relevance | Reference |
|---|---|---|
| "A substantial number of patients with head and neck paragangliomas (HNPGLs) have biochemically active tumors, evidenced by increased urinary excretion of catecholamines and metabolites, including 3-methoxytyramine (3MT)." | 3.79 | Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolites. ( Brookman, D; Corssmit, EP; de Jong, WH; Kema, IP; Romijn, JA; van Duinen, N, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Richter, S | 1 |
| Qiu, B | 1 |
| Ghering, M | 1 |
| Kunath, C | 1 |
| Constantinescu, G | 1 |
| Luths, C | 1 |
| Pamporaki, C | 1 |
| Bechmann, N | 1 |
| Meuter, L | 1 |
| Kwapiszewska, A | 1 |
| Deutschbein, T | 1 |
| Nölting, S | 1 |
| Peitzsch, M | 1 |
| Robledo, M | 1 |
| Prejbisz, A | 1 |
| Pacak, K | 1 |
| Gudziol, V | 1 |
| Timmers, HJLM | 1 |
| Eisenhofer, G | 1 |
| van Duinen, N | 2 |
| Corssmit, EP | 2 |
| de Jong, WH | 1 |
| Brookman, D | 1 |
| Kema, IP | 4 |
| Romijn, JA | 2 |
| Osinga, TE | 2 |
| Korpershoek, E | 1 |
| de Krijger, RR | 1 |
| Kerstens, MN | 1 |
| Dullaart, RP | 2 |
| van der Laan, BF | 2 |
| van der Horst-Schrivers, AN | 2 |
| Links, TP | 1 |
| Steenvoorden, D | 1 |
| Jansen, JC | 1 |
| Vriends, AH | 1 |
| Bayley, JP | 1 |
| Smit, JW | 1 |
5 other studies available for 3-methoxytyramine and Head and Neck Neoplasms
| Article | Year |
|---|---|
Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine.
Topics: Catecholamines; Dopamine; Female; Head and Neck Neoplasms; Humans; Male; Mutation; Normetanephrine; | 2022 |
Plasma levels of free metanephrines and 3-methoxytyramine indicate a higher number of biochemically active HNPGL than 24-h urinary excretion rates of catecholamines and metabolites.
Topics: Adolescent; Adult; Aged; Algorithms; Biomarkers; Catecholamines; Cohort Studies; Cross-Sectional Stu | 2013 |
Catecholamine-Synthesizing Enzymes Are Expressed in Parasympathetic Head and Neck Paraganglioma Tissue.
Topics: Aromatic-L-Amino-Acid Decarboxylases; Dopamine; Dopamine beta-Hydroxylase; Female; Head and Neck Neo | 2015 |
Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas.
Topics: 3-Iodobenzylguanidine; Catecholamines; Cross-Sectional Studies; Dopamine; Female; Head and Neck Neop | 2010 |
Dopamine excess in patients with head and neck paragangliomas.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Dopamine; Epinephrine; Female; Head and Neck Neoplas | 2010 |